Cost of Patients with Primary Open-angle Glaucoma A Retrospective Study of Commercial Insurance Claims Data

摘要: Purpose Primary open-angle glaucoma (POAG) poses a large burden on eye care resources in the United States. We evaluated total health and POAG-specific charges (both pharmacy nonpharmacy) incurred by patients with POAG using longitudinal U.S. commercial insurance claims database to determine relative magnitude of overall for those glaucoma. Design Retrospective cohort design. Participants Sixty-four thousand three hundred eighty were identified. Methods Patients selected (International Classification Diseases, 9th Revision code 365.11 at least 2 encounters) from managed database. Total calculated. Component (pharmacy also charge per treated person was Main Outcome Measure Health charges. Results The mean first year after initial entry into $13 404 (standard deviation [SD], $33 987), median $5403. $1570 (SD, $3428), $840. Pharmacy 25% subsequent years decreased 7% year, whereas increased 39% year. aged 65 older had significantly higher both ($16 759 vs. $11 651; P = 0.0049), an age-related increase 44% 5% Overall, represented 12% 8% years. Conclusions There is substantial cost associated population insurance, most these are not related.